Uzma Fazilath, Mohan Chakrabhavi D, Hashem Abeer, Konappa Narasimha M, Rangappa Shobith, Kamath Praveen V, Singh Bhim P, Mudili Venkataramana, Gupta Vijai K, Siddaiah Chandra N, Chowdappa Srinivas, Alqarawi Abdulaziz A, Abd Allah Elsayed F
Microbial Metabolite Research Laboratory, Department of Microbiology and Biotechnology, Bangalore University, Bangalore, India.
Department of Studies in Molecular Biology, University of Mysore, Mysore, India.
Front Pharmacol. 2018 Apr 26;9:309. doi: 10.3389/fphar.2018.00309. eCollection 2018.
Cancer is a major cause of death worldwide, with an increasing number of cases being reported annually. The elevated rate of mortality necessitates a global challenge to explore newer sources of anticancer drugs. Recent advancements in cancer treatment involve the discovery and development of new and improved chemotherapeutics derived from natural or synthetic sources. Natural sources offer the potential of finding new structural classes with unique bioactivities for cancer therapy. Endophytic fungi represent a rich source of bioactive metabolites that can be manipulated to produce desirable novel analogs for chemotherapy. This review offers a current and integrative account of clinically used anticancer drugs such as taxol, podophyllotoxin, camptothecin, and vinca alkaloids in terms of their mechanism of action, isolation from endophytic fungi and their characterization, yield obtained, and fungal strain improvement strategies. It also covers recent literature on endophytic fungal metabolites from terrestrial, mangrove, and marine sources as potential anticancer agents and emphasizes the findings for cytotoxic bioactive compounds tested against specific cancer cell lines.
癌症是全球主要的死亡原因,每年报告的病例数不断增加。死亡率的上升使得探索新型抗癌药物来源成为一项全球性挑战。癌症治疗的最新进展包括发现和开发源自天然或合成来源的新型改良化疗药物。天然来源具有发现具有独特生物活性的新结构类别用于癌症治疗的潜力。内生真菌是生物活性代谢物的丰富来源,可以对其进行操控以生产用于化疗的理想新型类似物。本综述对临床使用的抗癌药物,如紫杉醇、鬼臼毒素、喜树碱和长春花生物碱,在其作用机制、从内生真菌中的分离及其表征、获得的产量以及真菌菌株改良策略等方面进行了当前的综合阐述。它还涵盖了有关来自陆地、红树林和海洋来源的内生真菌代谢物作为潜在抗癌剂的最新文献,并强调了针对特定癌细胞系测试的细胞毒性生物活性化合物的研究结果。